European regulators have given LivaNova CE Mark approval for expanded MRI safety labeling of the company's Vagus Nerve Stimulation Therapy systems, including the AspireHC and AspireSR devices. The approval enables users of the devices to safely undergo 1.5T and 3T MRI scans without special equipment.
EU expands MRI safety labeling for LivaNova's VNS systems
Sign up for AdvaMed SmartBrief
Medical technology news
Get the intelligence you need: news and information that is changing your industry today, hand-curated by our professional editors from thousands of sources and delivered straight to your inbox.